| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
6,567 | 18,517 | 15,288 | - | - | - | - | - | - |
Revenue | ||||||||
- | - | - | 7,141 | 1,447 | 90 | 152 | 1,080 | 671 |
Cost of revenue | ||||||||
5,551 | 11,197 | 7,844 | 4,612 | 985 | 50 | 182 | 541 | 426 |
Gross profit | ||||||||
1,016 | 7,320 | 7,444 | 2,529 | 462 | 40 | -30 | 539 | 245 |
Operating expenses: | ||||||||
Research and development | ||||||||
8,590 | 13,616 | 12,343 | 8,365 | 4,988 | 1,426 | 772 | 2,031 | 1,212 |
Selling, general and administrative | ||||||||
22,363 | 38,669 | 28,831 | 12,868 | 7,464 | 4,276 | 3,129 | 2,633 | 2,445 |
Restructuring costs | ||||||||
742 | - | - | - | - | - | - | - | - |
Total operating expenses | ||||||||
31,695 | 52,285 | 41,174 | 21,233 | 12,452 | 5,702 | 3,901 | 4,664 | 3,657 |
Loss from operations | ||||||||
-30,679 | -44,965 | -33,730 | -18,704 | -11,990 | -5,662 | -3,931 | -4,125 | - |
Loss on debt restructuring | ||||||||
-6,705 | - | - | - | - | - | - | - | - |
Interest income | ||||||||
- | - | - | - | - | - | - | - | 10 |
Gain on the sale of assets | ||||||||
- | - | - | - | - | - | - | - | 40 |
Loss from operations | ||||||||
- | - | - | - | - | - | - | - | -3,372 |
Interest expense, net | ||||||||
4,354 | 4,372 | 3,169 | 1,370 | 415 | 567 | 447 | 555 | 396 |
Other expense, net | ||||||||
-161 | 13 | -60 | -37 | -21 | 49 | 61 | - | - |
Net loss from consolidated companies | ||||||||
-41,899 | -49,324 | -36,959 | - | - | - | - | - | -6,990 |
Loss from minority interest in limited liability company | ||||||||
-627 | -657 | - | - | - | - | - | - | - |
Foreign currency transaction gains (losses) | ||||||||
- | - | - | - | - | - | - | 14 | - |
Financing costs associated with convertible notes | ||||||||
- | - | - | - | - | - | - | 80 | 530 |
Change in fair value of warrant and option liabilities | ||||||||
- | - | - | - | - | - | - | -1,617 | -808 |
Change in fair value of convertible notes | ||||||||
- | - | - | - | - | - | - | -2,024 | -1,894 |
Total other income (expense) | ||||||||
- | - | - | - | - | - | - | -4,262 | -3,618 |
Comprehensive and net loss | ||||||||
-42,526 | -49,981 | -36,959 | -20,111 | -12,426 | -6,180 | -4,317 | - | - |
Series B convertible preferred stock dividends | ||||||||
380 | - | - | - | - | - | - | - | - |
Benefit for income taxes from continuing operations | ||||||||
- | - | - | - | - | - | - | - | -492 |
Net loss from continuing operations, net of income taxes | ||||||||
- | - | - | - | - | - | - | - | -6,498 |
Income from discontinued operations | ||||||||
- | - | - | - | - | - | - | - | 53 |
Gain on sale of discontinued operations, net of provision for income taxes of $492 | ||||||||
- | - | - | - | - | - | - | - | 687 |
Net income from discontinued operations, net of income taxes | ||||||||
- | - | - | - | - | - | - | - | 740 |
Net loss attributable to common stockholders | ||||||||
-42,906 | -49,981 | - | - | - | - | - | -8,387 | -5,758 |
Net loss per share of common stock: | ||||||||
From loss on continuing operations attributable to common stockholders (in dollars per share) | ||||||||
- | - | - | - | - | - | - | - | -0.21 |
From income on discontinued operations (in dollars per share) | ||||||||
- | - | - | - | - | - | - | - | 0.00 |
From gain on sale of discontinued operations (in dollars per share) | ||||||||
- | - | - | - | - | - | - | - | 0.02 |
Basic and diluted (in dollars per share) | ||||||||
-34.39 | -160.92 | -2.11 | -2.18 | -2.47 | -1.27 | -81.81 | - | -0.19 |
Weighted average shares used in computing net loss per common share: | ||||||||
Basic and diluted (in shares) | ||||||||
1,247 | 310 | 17,496 | 9,222 | 5,023 | 4,865 | 52 | - | - |
Net loss per weighted average share, basic (in Dollars per share) | ||||||||
- | - | - | - | - | - | - | -0.27 | - |
Basic (in Shares) | ||||||||
- | - | - | - | - | - | - | 31,139 | 30 |
Diluted (in Shares) | ||||||||
- | - | - | - | - | - | - | 31,139 | 30 |